» Articles » PMID: 19841180

Activation-induced CD154 Expression Abrogates Tolerance Induced by Apoptotic Cells

Overview
Journal J Immunol
Date 2009 Oct 21
PMID 19841180
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The decision to generate a productive immune response or tolerance often depends on the context in which T cells first see Ag. Using a classical system of tolerance induction, we examined the immunological consequence of Ag encountered in the presence of naive or activated apoptotic cells. Naive apoptotic cells induced tolerance when injected i.v.; however, previously activated apoptotic cells induced immunity. Further analysis revealed a key role for CD154, as tolerance resulted after i.v. injection of either naive or activated apoptotic CD154(-/-) T cells, while coinjection of an agonistic anti-CD40 mAb with naive apoptotic T cells induced robust immunity. Dendritic cells fed activated apoptotic T cells in vitro produced IL-12p40 in a CD154-dependent manner, and the use of IL-12p40(-/-) mice or mAb-mediated neutralization of IL-12 revealed a link between CD154, IL-12, and the ability of activated apoptotic T cells to induce immunity rather than tolerance. Collectively, these results show that CD154 expression on apoptotic T cells can determine the outcome of an immune response to Ag recognized within the context of the apoptotic cells and suggest that the balance between naive and activated apoptotic T cells may dictate whether a productive immune response is encouraged.

Citing Articles

CD8 T cells specific for cryptic apoptosis-associated epitopes exacerbate experimental autoimmune encephalomyelitis.

Feizi N, Focaccetti C, Pacella I, Tucci G, Rossi A, Costanza M Cell Death Dis. 2021; 12(11):1026.

PMID: 34716313 PMC: 8556378. DOI: 10.1038/s41419-021-04310-6.


Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD).

Mankarious M, Matthews N, Snowden J, Alfred A Front Immunol. 2020; 11:81.

PMID: 32082329 PMC: 7005102. DOI: 10.3389/fimmu.2020.00081.


Multiple effects of CD40-CD40L axis in immunity against infection and cancer.

Ara A, Ahmed K, Xiang J Immunotargets Ther. 2018; 7:55-61.

PMID: 29988701 PMC: 6029590. DOI: 10.2147/ITT.S163614.


Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease.

Morelli A, Larregina A Stem Cells. 2016; 34(5):1142-50.

PMID: 26865545 PMC: 4860051. DOI: 10.1002/stem.2326.


CD8+ T Cells Specific to Apoptosis-Associated Antigens Predict the Response to Tumor Necrosis Factor Inhibitor Therapy in Rheumatoid Arthritis.

Citro A, Scrivo R, Martini H, Martire C, De Marzio P, Vestri A PLoS One. 2015; 10(6):e0128607.

PMID: 26061065 PMC: 4465029. DOI: 10.1371/journal.pone.0128607.


References
1.
Williams C, Harry R, McLeod J . Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO. Immunology. 2007; 124(1):89-101. PMC: 2434374. DOI: 10.1111/j.1365-2567.2007.02743.x. View

2.
Gorbachev A, DiIulio N, Fairchild R . IL-12 augments CD8+ T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition. J Immunol. 2001; 167(1):156-62. DOI: 10.4049/jimmunol.167.1.156. View

3.
BATTISTO J, Bloom B . Dual immunological unresponsiveness induced by cell membrane coupled hapten or antigen. Nature. 1966; 212(5058):156-7. DOI: 10.1038/212156a0. View

4.
Zhu J, Paul W . CD4 T cells: fates, functions, and faults. Blood. 2008; 112(5):1557-69. PMC: 2518872. DOI: 10.1182/blood-2008-05-078154. View

5.
Fadok V, Voelker D, Campbell P, Cohen J, Bratton D, Henson P . Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992; 148(7):2207-16. View